跳至主要内容
临床试验/NCT03038503
NCT03038503Unknown3 期

What Should be the Next Vasopressor for Severe Septic Shock Patients? Methylene Blue or Terlipressin

Ramathibodi Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
60
试验地点
1
主要终点
mortality rate

研究概览

简要总结

The ICU mortality rate of patients with septic shock was still high upto 54.1%.In first 6 hours of resuscitation, the goals of resuscitation in sepsis shock after adequate fluid resuscitation is MAP ≥65 mmHg. In refractory septic shock patient, prolong shock correlate with poor outcome due to multiple organ failure. Alternative vasopressor in septic shock with catecholamine resistance has been studied such as terlipressin, methylene blue

  • Terlipressin (TP) mediate vasoconstriction via V1 receptors coupled to phospholipase C, and increases intracellular Ca2+ concentration
  • Methylene blue (MB) directly inhibits nitric oxide synthase (NOS) by inhibit the enzyme guanylate cyclase (GC)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >15 years old
  • Diagnosis septic shock as SCCM/ACCP
  • Refractory septic shock defined as hypotension although adequate fluid resuscitate and high dose vasopressor(NE >0.5 mcg/kg/min)
  • Concent form

排除标准

  • Known case G6PD deficiency
  • Acute respiratory distress syndrome (ARDS)
  • Hx of drug allergy MB, NE, terlipressin
  • Hx of Raynaud's phenomenon, systemic sclerosis, PHT
  • Known case coronary heart disease without treatment
  • Current drug use serotonin reuptake inhibitors (SSRI), Serotonin and norepinephrine reuptake inhibitors (SNRIs)
  • Reject to join project

研究组 & 干预措施

B

Experimental

after defined refractory shock (adequate fluid resuscitation + add NE>0.5 mcg/kg/min) add Methylene blue 1 mg/kg iv drip then 2 hr later drip 0.5 mg/kg/hr*4 hr (intervention add on to standard care)

干预措施: Methylene Blue (Drug)

C

Experimental

after defined refractory shock (adequate fluid resuscitation + add NE>0.5 mcg/kg/min) add terlipressin 1 mg IV then repeated dose 20 min later if unstable BP (intervention add on to standard care)

干预措施: Terlipressin (Drug)

结局指标

主要结局

mortality rate

时间窗: 7 days

ICU duration

时间窗: through out off indication need ICU care, an average of 7 days

time to wean of vasopressor

时间窗: through complete weaning off vasopressor, an average of 24 hours

次要结局

  • hemodynamic parameter: lactate (mmol/l)(every 2 hr until 6 hr then every 4 hr until wean off vasopressor up to 24 hours)
  • hemodynamic parameter: Mean arterial pressure (mmHg)(every 30 min after start protocol up to 6 hr then every 1 hr up to 24 hours)
  • hemodynamic parameter: urine output (ml)(every 2 hr until wean off vasopressor up to 24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

munthana sundusadee

fellowship in department of pulmonary and critical care department

Ramathibodi Hospital

研究点 (1)

Loading locations...

相似试验